SCHEMBL3133548

SCHEMBL3133548

CC(O)C(O)OC(=O)CCCCCCCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
TSHR P16473 6/20 0.46
NFKB1 P19838 1/20 0.46
PMP22 Q01453 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
GPR84 Q9NQS5 8/20 0.45
FFAR1 O14842 2/20 0.45
FFAR4 Q5NUL3 2/20 0.45
ALDH1A1 P00352 3/20 0.44
PPARG P37231 6/20 0.43
PPARD Q03181 6/20 0.43
PPARA Q07869 6/20 0.43
HDAC11 Q96DB2 5/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
PTPN1 P18031 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL9146573 0.93 LMNA (0.61) LMNATSHRMAPTMAPK1GPR84
SCHEMBL10936262 0.90 LMNA (0.52) LMNATSHRMAPTMAPK1ALDH1A1
SCHEMBL4245440 0.86 KDM2A (0.43) LMNATSHRMAPTMAPK1
SCHEMBL15665851 0.85 LMNA (0.69) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL15666622 0.85 LMNA (0.69) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL27324519 0.84 LMNA (0.52) LMNATSHRNFKB1PMP22GPR84
SCHEMBL28798937 0.84 LMNA (0.52) LMNATSHRNFKB1PMP22GPR84
SCHEMBL8618104 0.82 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1MEN1
SCHEMBL28017731 0.82 TSHR (0.47) LMNATSHRNFKB1PMP22GPR84
SCHEMBL14809112 0.82 LMNA (0.70) LMNATSHRNFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12090243-B2 Compositions comprising fluid gels for tissue separation ALEO BME, INC. (US) 2024-09-17 US claimed
EP-4313171-A1 COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION Aleo BME, Inc. (US) 2024-02-07 EP claimed
US-20220305171-A1 COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION ALEO BME, INC. 2022-09-29 US claimed
WO-2022204110-A1 COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION ALEO BME, INC. (US) 2022-09-29 WO claimed
US-20060039980-A1 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-02-23 US claimed
US-12090243-B2 Compositions comprising fluid gels for tissue separation ALEO BME, INC. (US) 2024-09-17 US disclosed
EP-4313171-A1 COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION Aleo BME, Inc. (US) 2024-02-07 EP disclosed
WO-2022204110-A1 COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION ALEO BME, INC. (US) 2022-09-29 WO disclosed
US-20220305171-A1 COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION ALEO BME, INC. 2022-09-29 US disclosed
US-20140276995-A1 4D Dynamically Contouring Mesh and Sutures NOVO IP, LLC 2014-09-18 US disclosed
US-20130090521-A1 TIMED-RELEASE TENSIONED OR COMPRESSED FIBERS NOVO CONTOUR, INC. (US) 2013-04-11 US disclosed
US-7642075-B2 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-01-05 US disclosed
US-20060039980-A1 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060039980-A1 Process of preparing a biodegradable polymer using an enzyme catalyst and a biodegradable polymer prepared through the process HPD, DERA, ADH1C LMNA 2352/4885TSHR 3020/4885NFKB1 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.